View in EDS HTML Full Text PDF Full Text

Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies.

Saved in:
Bibliographic Details
Title: Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies.
Authors: Nacer A; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Kivi G; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Pert R; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Juronen E; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Holenya P; Research and Development, JPT Peptide Technologies GmbH, Berlin, Germany., Aliprandini E; Malaria Infection & Immunity Unit, Institut Pasteur, Paris, France., Amino R; Malaria Infection & Immunity Unit, Institut Pasteur, Paris, France., Silvie O; Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France., Quinkert D; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Le Duff Y; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Hurley M; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Reimer U; Research and Development, JPT Peptide Technologies GmbH, Berlin, Germany., Tover A; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Draper SJ; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Gilbert S; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Ho MM; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Bowyer PW; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom.
Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 Jun 16; Vol. 12, pp. 901253. Date of Electronic Publication: 2022 Jun 16 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35782147
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nacer+A%22">Nacer A</searchLink>; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kivi+G%22">Kivi G</searchLink>; Icosagen Cell Factory OÜ, Tartumaa, Estonia.<br /><searchLink fieldCode="AU" term="%22Pert+R%22">Pert R</searchLink>; Icosagen Cell Factory OÜ, Tartumaa, Estonia.<br /><searchLink fieldCode="AU" term="%22Juronen+E%22">Juronen E</searchLink>; Icosagen Cell Factory OÜ, Tartumaa, Estonia.<br /><searchLink fieldCode="AU" term="%22Holenya+P%22">Holenya P</searchLink>; Research and Development, JPT Peptide Technologies GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Aliprandini+E%22">Aliprandini E</searchLink>; Malaria Infection & Immunity Unit, Institut Pasteur, Paris, France.<br /><searchLink fieldCode="AU" term="%22Amino+R%22">Amino R</searchLink>; Malaria Infection & Immunity Unit, Institut Pasteur, Paris, France.<br /><searchLink fieldCode="AU" term="%22Silvie+O%22">Silvie O</searchLink>; Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Quinkert+D%22">Quinkert D</searchLink>; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Le+Duff+Y%22">Le Duff Y</searchLink>; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hurley+M%22">Hurley M</searchLink>; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Reimer+U%22">Reimer U</searchLink>; Research and Development, JPT Peptide Technologies GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Tover+A%22">Tover A</searchLink>; Icosagen Cell Factory OÜ, Tartumaa, Estonia.<br /><searchLink fieldCode="AU" term="%22Draper+SJ%22">Draper SJ</searchLink>; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gilbert+S%22">Gilbert S</searchLink>; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ho+MM%22">Ho MM</searchLink>; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bowyer+PW%22">Bowyer PW</searchLink>; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101585359%22">Frontiers in cellular and infection microbiology</searchLink> [Front Cell Infect Microbiol] 2022 Jun 16; Vol. 12, pp. 901253. <i>Date of Electronic Publication: </i>2022 Jun 16 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+SA%22">Frontiers Media SA </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101585359 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2235-2988 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222352988%22">22352988 </searchLink><i>NLM ISO Abbreviation: </i>Front Cell Infect Microbiol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35782147
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fcimb.2022.901253
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 901253
    Titles:
      – TitleFull: Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nacer A
      – PersonEntity:
          Name:
            NameFull: Kivi G
      – PersonEntity:
          Name:
            NameFull: Pert R
      – PersonEntity:
          Name:
            NameFull: Juronen E
      – PersonEntity:
          Name:
            NameFull: Holenya P
      – PersonEntity:
          Name:
            NameFull: Aliprandini E
      – PersonEntity:
          Name:
            NameFull: Amino R
      – PersonEntity:
          Name:
            NameFull: Silvie O
      – PersonEntity:
          Name:
            NameFull: Quinkert D
      – PersonEntity:
          Name:
            NameFull: Le Duff Y
      – PersonEntity:
          Name:
            NameFull: Hurley M
      – PersonEntity:
          Name:
            NameFull: Reimer U
      – PersonEntity:
          Name:
            NameFull: Tover A
      – PersonEntity:
          Name:
            NameFull: Draper SJ
      – PersonEntity:
          Name:
            NameFull: Gilbert S
      – PersonEntity:
          Name:
            NameFull: Ho MM
      – PersonEntity:
          Name:
            NameFull: Bowyer PW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 06
              Text: 2022 Jun 16
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2235-2988
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in cellular and infection microbiology
              Type: main
ResultId 1